← Back
$TNGX All transactions

Tango Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$694K

Shares

54,345

Price

$13

Filed

Feb 27

Insider

Name

Crystal Adam

Title

President, R&D

CIK

0001825445

Roles

Officer

Transaction Details

Transaction Date

2026-02-25

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

132,873

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025. | Represents the weighted average sales price per share. The shares sold at prices ranging from $12.61 to $13.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Filing Info

Accession No.

0001193125-26-083579

Form Type

4

Issuer CIK

0001819133

Crystal Adam's History

Date Ticker Type Value
2026-04-15 TNGX M $200K
2026-04-15 TNGX $962K
2026-04-15 TNGX M $0
2026-04-01 TNGX M $140K
2026-04-01 TNGX $572K
2026-04-01 TNGX M $0
2026-03-25 TNGX M $62K
2026-03-25 TNGX $241K
2026-03-25 TNGX M $0
2026-02-25 TNGX $694K

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$2.0M 2026-04-15